SEC Comment Letter for MERIDIAN BIOSCIENCE INC (CIK 0000794172) — Nov 25, 2020
MERIDIAN BIOSCIENCE INC (CIK 0000794172)
Date: Nov. 25, 2020 · CIK: 0000794172 · Accession: 0000000000-20-011344
AI Filing Summary & Sentiment
File numbers found in text: 333-250878
Letter
United States securities and exchange commission logo November 25, 2020 Bryan Baldasare Executive Vice President, Chief Financial Officer MERIDIAN BIOSCIENCE INC 3471 River Hills Drive Cincinnati, Ohio 45244 Re:MERIDIAN BIOSCIENCE INC Registration Statement on Form S-3 Filed November 23, 2020 File No. 333-250878 Dear Mr. Baldasare: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Margaret Schwartz at 202-551-7153 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: F. Mark Reuter, Esq.
Show Raw Text
United States securities and exchange commission logo
November 25, 2020
Bryan Baldasare
Executive Vice President, Chief Financial Officer
MERIDIAN BIOSCIENCE INC
3471 River Hills Drive
Cincinnati, Ohio 45244
Re:MERIDIAN BIOSCIENCE INC
Registration Statement on Form S-3
Filed November 23, 2020
File No. 333-250878
Dear Mr. Baldasare:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Margaret Schwartz at 202-551-7153 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: F. Mark Reuter, Esq.